DOMS Industries / Q2-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2025-11-06Back to DOMS

Revenue

₹567.9 Cr

verified against source

Revenue YoY

24.1%

reported change

EBITDA

₹99.5 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
EBITDA (₹ Cr)PositiveWatchNegative
3 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY26: 98.7 · Positive source sentiment · 2025-08-06Q1 FY26Q2 FY26: 99.5 · Positive source sentiment · 2025-11-06Q2 FY26Q3 FY26: 103.4 · Positive source sentiment · 2026-02-10Q3 FY26103.498.7
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

DOMS Industries reported Q2 FY26 consolidated revenue of ₹567.9 crore (+24.1% YoY), EBITDA of ₹99.5 crore (+15.8% YoY), and PAT of ₹60.9 crore (+13.4% YoY). Growth was driven by strong domestic volume growth (+28% gross product sales) and steady exports (+18.5%), despite a temporary GST 2.0 transition impact that reduced sales by an estimated 3-4%. EBITDA margin of 17.5% remained within the guided 16.5-17.5% range. Management maintained FY26 revenue growth guidance of 18-20%, citing capacity constraints in core stationary categories. The 44-acre expansion project faces slight delays due to monsoons, with first building possession expected in Q4 FY26 and commercial production from Q1 FY27. Key risk: US tariffs may impact export orders, though management is diverting capacity to other markets.

Colored figures show movement against the previous available record.

Guidance to track

  • Management reiterated full-year revenue growth guidance of 18-20%, noting that H1 growth was boosted by full consolidation of Unigland Healthcare.
  • Management expects EBITDA margins to remain in the 16.5-17.5% range, supported by operational efficiencies.
  • Consolidated capex of ~₹150 crore in H1 FY26; full-year capex expected in the ₹210-225 crore range.
  • First building possession expected in Q4 FY26, with commercial production starting in Q1 FY27, initially for pencil capacity.

Risks flagged

  • US tariffs introduced in September may reduce export orders; management has diverted capacity to other markets but impact is uncertain.
  • GST rate reduction to 0% on ~45% of products caused temporary inventory clearance and order postponement, impacting Q2 sales by 3-4%.
  • Scholastic stationary and art material growth was only ~4% YoY due to lack of capacity additions; new capacity only from Q1 FY27.
  • Employee costs rose 85 bps as a percentage of sales due to advance hiring for expansion and GST disruption; operating leverage may be delayed.

Key quotes

  • Despite the impact of GST 2.0 transition we continued our growth momentum in Q2 FY26 with an increase in sales of over 24%.
  • If this transition impact would not be there our sales could have been about 3 to 4% higher than what we've reported for the quarter.
  • We believe these reforms coupled with the income tax reductions introduced in budget 2025 will have a long-term positive impact.

Research modules

Go one layer deeper.